Clinicopathological observation on ovarian masses in childhood and adolescence.
- Author:
Ji Hee YOO
1
;
Joo Myung KIM
;
Yeon Jean CHO
;
Ji Hyoung YOOK
;
Hee Suk LEE
;
Mi La KIM
;
Kwan Young JOO
Author Information
1. Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea. mila76@naver.com
- Publication Type:Case Report
- Keywords:
Ovarian mass;
Childhood;
Adolescence
- MeSH:
Adolescent;
Cystectomy;
Female;
Fertility;
Follow-Up Studies;
Germ Cells;
Hospitals, General;
Humans;
Incidence;
Ovary;
Recurrence;
Retrospective Studies;
Teratoma
- From:Korean Journal of Obstetrics and Gynecology
2009;52(6):636-643
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The purpose of this study was to describe the clinical presentation and histopathologic findings that help in decisions about management of ovarian mass in childhood and adolescence. METHODS:We retrospectively analyzed the data on 307 patients with surgically treated ovarian mass under 20 years of age at the Cheil General Hospital, between January 1995 and December 2005. RESULTS: Of the 307 cases, 40 cases (13%) were ovarian malignancy. The incidence of malignant ovarian tumor increased to 16.9% in 237 neoplastic tumors. Epithelial, germ cell, and sex-cord stromal malignancies accounted for 57.5%, 30% and 12.5%, respectively, of the 40 ovarian malignancies. The stage of the 35 cases (87.5%) with the ovarian malignancy was the FIGO stage I. The incidence of ovarian malignancies increased with larger size, higher CA125 level. Solid ovarian masses on ultrasound were more likely ovarian malignancy. But age and menarchal status was not correlated with ovarian malignancy. Mature cystic teratoma seen in 132 patients (55.7%), was the most common neoplasm of ovary in this age group, and the incidence of bilaterality was 12.1%. On follow up, 4.9% (13/267) of previously diagnosed benign ovarian tumor were reoperated due to recurred or newly developed ovarian tumor. After cystectomy, the recurrence rate of ipsilateral ovarian tumor was 2.8% (4/142). CONCLUSION: If there is no evidence of malignancy, conservative surgical treatment should be employed to preserve future endocrine function and fertility in this age group.
